NCT02885974 2025-07-28
BLAST
Baylor College of Medicine
Phase 1 Completed
Clinical Trials
9 trialsNCT00022399 2019-02-08
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01220973 2018-06-08
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT02343614 2015-01-22
Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Phase 2 Completed
NCT01678313 2014-07-15
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
Buddhist Tzu Chi General Hospital
Phase 2 Completed
NCT00213694 2013-03-05
PROSTACOX : Metastatic Prostate Chemotherapy
University Hospital, Rouen
Completed
NCT00006124 2013-02-13
Celecoxib in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT01158534 2012-08-07
Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00136487 2009-12-09
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2/3 Completed